ClinConnect ClinConnect Logo
Search / Trial NCT06275009

Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina)

Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · Feb 17, 2024

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Lifestyle Physical Fitness Cardiovascular Diseases Cohort

ClinConnect Summary

The LiFitChina trial is a study aimed at understanding how lifestyle and physical fitness affect heart health among working adults in China. Researchers are looking at factors like diet, exercise, sleep, and stress to see how they relate to conditions such as obesity, high blood pressure, diabetes, and heart disease. The study will follow adults aged 18 to 59 who have no history of serious heart issues or certain other health conditions. Participants will be monitored over time, providing information about their daily habits and health, helping researchers learn how these factors can influence heart health.

If you join the study, you’ll be asked to share details about your lifestyle and undergo health check-ups. The goal is to create a better understanding of how everyday choices can impact cardiovascular health, ultimately helping to reduce the risk of heart disease in the workplace. It's a chance to contribute to important research that could benefit many people in the future!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adults between 18-59 years of age
  • occupational staff
  • willing to accept long-term follow-up
  • Exclusion Criteria:
  • participants with previous CVD history such as myocardial infarction, stroke and severe aortic stenosis;
  • with cancer;
  • with congenital genetic diseases, or cannot cooperate with the investigation and follow-up due to acquired diseases, such as congenital heart disease, paralysis, deafness, dementia, mental abnormality, developmental retardation, etc.;
  • with exercise contraindications;
  • duration of pregnancy;
  • refuse to sign the informed consent.

About China National Center For Cardiovascular Diseases

The China National Center for Cardiovascular Diseases (NCCD) is a leading research and clinical trial sponsor dedicated to advancing cardiovascular health in China and globally. As a prominent institution, NCCD focuses on innovative research, clinical management, and education in cardiovascular medicine. The center plays a crucial role in conducting rigorous clinical trials aimed at developing new therapies and improving patient outcomes for cardiovascular diseases. Through collaboration with national and international partners, NCCD is committed to enhancing the understanding of cardiovascular conditions and translating research findings into practical applications for improved healthcare.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported